Organization
Halozyme Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Halozyme Therapeutics, Inc.
... investment community. Today we are offering reports on OPHT, TRVN, PTCT, and HALO which can be accessed for free by signing up tohttp://www.wallstequities.com/registration. This morning's ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, forecasts ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies will ...
... & SAN DIEGO - Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today a collaboration and license agreement that enables Alexion ...
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced today a collaboration and license agreement that enables Alexion ...
... investors, traders, and shareholders of Aramark (NYSE:ARMK), J.M. Smucker Company (NYSE:SJM), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Trinseo S.A. (NYSE:TSE), Camden Property Trust (NYSE:CPT), and Lions Gate ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies will ...
... If you want a Stock Review on ECYT, EDIT, HALO, or ILMN then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it will present nonclinical data at the ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the initiation of a multi-arm clinical trial evaluating ...
... Coordinator, Corporate Communications, Ionis Pharmaceuticals) Vice President-Treasurer Chris Burton (Director, Investor Relations, Halozyme Therapeutics) Vice President-Communications Jessica Dyas (Account Manager, Canale Communications) Â Vice President-Sponsorship ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced initiation of a clinical trial evaluating its investigational ...
... SAN DIEGO. - Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will ...
... reflects healthy market breadth, or participation." Oracle Corporation (NYSE: ORCL), Halozyme Therapeutics, Inc. (NASDAQ: HALO), Nordstrom, Inc. (NYSE: JWN), Aldeyra Therapeutics Inc. (NASDAQ: ALDX), Teva ...
... fund’s attempt to buy the chip maker for $1.3 billion. Shares of Halozyme Therapeutics gained 18% premarket. The biotechnology firm announced a license agreement with ...
... Bristol-Myers Squibb has paid Halozyme $105 million upfront to access drug delivery technology. The agreement positions Bristol-Myers ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today it licensed its ENHANZE® drug-delivery technology to Roche ...
... If you want a Stock Review on GRFS, HALO, ILMN, or VVUS then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies will ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
Want to see the full history on Halozyme Therapeutics, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial